Table 4. Brachytherapy for 70 cases with T₁ T₂ No Mo.

T Stage	T1	T2
PRE-Rx n	23	47
G2 – 6	10	15
7	1	9
8 – 10	1	3
Mean Pre-Rx PSA ng/ml	13.32 ± 0.24SE(6.1 – 38.07)	13.38 ± 0.34SE (2.5 – 69)
Post Follow up(10 – 72 mths)Mean 12 mths	20	41
POST Rx PSAng/ml meanrange	0.134 ± 0.06SE(0.01 – 7.9)	0.234 ± 0.056SE(0.01 – 57.3)
pre vs post PSA	P< 0.0001	P< 0.0001
Biochemical Failure (BF)	1	2 Rx EBRT/ Hormone therapy